CareDx, Inc (CDNA) vs Parabilis Medicines, Inc. (PBLS)

A side-by-side comparison of CareDx, Inc and Parabilis Medicines, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
CareDx, Inc logo
CDNA
CareDx, Inc
$3.30B
$63.79HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Parabilis Medicines, Inc. logo
PBLS
Parabilis Medicines, Inc.
$3.36B
$28.86HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — CDNA vs PBLS

growth of $100 · dividends reinvested · last 1y
CDNA +202.1% (+202.1%/yr)PBLS +47.7% (+47.7%/yr)CDNA compounded faster over this window
100150200250300Start $100$302$148
CDNA PBLS

CDNA vs PBLS: by the numbers

  • •PBLS is the larger company ($3.36B vs $3.30B market cap).
  • •CDNA is profitable (24.23% net margin) while PBLS runs a net loss (0.00%).

Metrics side by side

Valuation

MetricCDNAPBLS
P/E ratio30.80N/A
Forward P/E53.26N/A
P/S ratio7.20N/A
P/B ratio7.753.21
EV / EBITDA189.34N/A
FCF yield2.58%N/A

Profitability

MetricCDNAPBLS
Gross margin70.58%0.00%
Operating margin-0.92%0.00%
Net margin24.23%0.00%
ROE26.08%N/A
ROIC-0.93%-409.85%

Growth (annualized)

MetricCDNAPBLS
Revenue CAGR (5Y)12.56%N/A
Total return CAGR (5Y)1.33%N/A

Frequently asked

Is CDNA or PBLS more profitable?
CDNA runs the higher net margin — CDNA at 24.23% versus PBLS at 0.00%.

Go deeper

Full CDNA analysisFull PBLS analysisInteractive comparison tool

Dig into the metrics

CareDx P/E ratioCareDx ROEParabilis Medicines ROECareDx operating marginParabilis Medicines operating marginCareDx revenue growthParabilis Medicines revenue growthCareDx free cash flowParabilis Medicines free cash flow

CareDx & Parabilis Medicines appear in these rankings

Highest ROE StocksHighest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.